OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 144 filers reported holding OPHTHOTECH CORP in Q4 2016. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $454,000 | -32.7% | 124,132 | -11.2% | 0.00% | -100.0% |
| Q4 2016 | $675,000 | -89.5% | 139,742 | +0.2% | 0.00% | -75.0% |
| Q3 2016 | $6,431,000 | -10.6% | 139,404 | -1.1% | 0.00% | -33.3% |
| Q2 2016 | $7,197,000 | +40.6% | 141,025 | +16.4% | 0.01% | +50.0% |
| Q1 2016 | $5,120,000 | -47.1% | 121,130 | -1.7% | 0.00% | -42.9% |
| Q4 2015 | $9,678,000 | +86.2% | 123,237 | -4.0% | 0.01% | +75.0% |
| Q3 2015 | $5,199,000 | -18.2% | 128,311 | +5.1% | 0.00% | -20.0% |
| Q2 2015 | $6,358,000 | +34.4% | 122,134 | +20.1% | 0.01% | +66.7% |
| Q1 2015 | $4,732,000 | +9.9% | 101,706 | +6.0% | 0.00% | 0.0% |
| Q4 2014 | $4,306,000 | +64.7% | 95,962 | +42.9% | 0.00% | +50.0% |
| Q3 2014 | $2,615,000 | +16.4% | 67,163 | +26.5% | 0.00% | 0.0% |
| Q2 2014 | $2,247,000 | +77.8% | 53,112 | +50.2% | 0.00% | +100.0% |
| Q1 2014 | $1,264,000 | +10.5% | 35,354 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,144,000 | – | 35,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,053,143 | $95,533,000 | 31.57% |
| Clarus Ventures, LLC | 1,554,744 | $72,342,000 | 30.07% |
| Novo Holdings A/S | 4,910,487 | $228,485,000 | 19.43% |
| JHL Capital Group LLC | 3,265,000 | $151,920,000 | 13.98% |
| AlpInvest Partners B.V. | 37,500 | $1,745,000 | 3.26% |
| Opaleye Management Inc. | 105,000 | $4,886,000 | 2.27% |
| IMA Wealth, Inc. | 67,930 | $3,161,000 | 1.54% |
| Hillview Capital Advisors, LLC | 34,830 | $1,621,000 | 1.40% |
| Cheyne Capital Management (UK) LLP | 124,151 | $5,777,000 | 1.39% |
| WILLIAM HARRIS INVESTORS INC | 106,158 | $4,939,000 | 1.30% |